# Acumen Pharmaceuticals, Inc.: Form 8-K, filed Aug 13, 2024

- Company: [Acumen Pharmaceuticals, Inc.](/companies/abos.md) (CIK 1576885)
- Form: 8-K
- Filed: 2024-08-13
- Accepted by EDGAR: Aug 13, 2024, 07:48 ET
- Period: 2024-08-13
- Accession: 0001576885-24-000090
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1576885/000157688524000090/abos-20240813.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1576885/000157688524000090/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1576885/000157688524000090/abos-20240813.htm

Filed Aug 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001576885-24-000090. Last ingested by Listed: Oct 30, 2026, 07:07 ET. No prices; not investment advice.